Plasma Protein Therapeutics Market - Global Outlook and Forecast 2021-2027

January 2021 | 107 pages | ID: PDCDE2E2D5B4EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Plasma Protein Therapeutics in Global, including the following market information:
Global Plasma Protein Therapeutics Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Plasma Protein Therapeutics market was valued at 27040 million in 2020 and is projected to reach US$ 34800 million by 2027, at a CAGR of 6.5% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Plasma Protein Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Plasma Protein Therapeutics Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Plasma Protein Therapeutics Market Segment Percentages, By Type, 2020 (%)

• Coagulation Factor
• Immune Globulin
• Albumin
• Others

China Plasma Protein Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Plasma Protein Therapeutics Market Segment Percentages, By Application, 2020 (%)

• Hemophilia
• PID
• Others

Global Plasma Protein Therapeutics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Plasma Protein Therapeutics Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Plasma Protein Therapeutics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Plasma Protein Therapeutics Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:

• Shire (Baxalta)
• CSL
• Grifols
• Octapharma
• Kedrion
• LFB Group
• Biotest
• BPL
• RAAS
• CBPO
• Hualan Bio
• Kamada

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Plasma Protein Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Plasma Protein Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PLASMA PROTEIN THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Plasma Protein Therapeutics Market Size: 2021 VS 2027
2.2 Global Plasma Protein Therapeutics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Plasma Protein Therapeutics Players in Global Market
3.2 Top Global Plasma Protein Therapeutics Companies Ranked by Revenue
3.3 Global Plasma Protein Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Plasma Protein Therapeutics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Plasma Protein Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Plasma Protein Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Plasma Protein Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Plasma Protein Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Plasma Protein Therapeutics Market Size Markets, 2021 & 2027
  4.1.2 Coagulation Factor
  4.1.3 Immune Globulin
  4.1.4 Albumin
  4.1.5 Others
4.2 By Type - Global Plasma Protein Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Plasma Protein Therapeutics Revenue, 2016-2021
  4.2.2 By Type - Global Plasma Protein Therapeutics Revenue, 2022-2027
  4.2.3 By Type - Global Plasma Protein Therapeutics Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Plasma Protein Therapeutics Market Size, 2021 & 2027
  5.1.2 Hemophilia
  5.1.3 PID
  5.1.4 Others
5.2 By Application - Global Plasma Protein Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Plasma Protein Therapeutics Revenue, 2016-2021
  5.2.2 By Application - Global Plasma Protein Therapeutics Revenue, 2022-2027
  5.2.3 By Application - Global Plasma Protein Therapeutics Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Plasma Protein Therapeutics Market Size, 2021 & 2027
6.2 By Region - Global Plasma Protein Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Plasma Protein Therapeutics Revenue, 2016-2021
  6.2.2 By Region - Global Plasma Protein Therapeutics Revenue, 2022-2027
  6.2.3 By Region - Global Plasma Protein Therapeutics Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Plasma Protein Therapeutics Revenue, 2016-2027
  6.3.2 US Plasma Protein Therapeutics Market Size, 2016-2027
  6.3.3 Canada Plasma Protein Therapeutics Market Size, 2016-2027
  6.3.4 Mexico Plasma Protein Therapeutics Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Plasma Protein Therapeutics Revenue, 2016-2027
  6.4.2 Germany Plasma Protein Therapeutics Market Size, 2016-2027
  6.4.3 France Plasma Protein Therapeutics Market Size, 2016-2027
  6.4.4 U.K. Plasma Protein Therapeutics Market Size, 2016-2027
  6.4.5 Italy Plasma Protein Therapeutics Market Size, 2016-2027
  6.4.6 Russia Plasma Protein Therapeutics Market Size, 2016-2027
  6.4.7 Nordic Countries Plasma Protein Therapeutics Market Size, 2016-2027
  6.4.8 Benelux Plasma Protein Therapeutics Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Plasma Protein Therapeutics Revenue, 2016-2027
  6.5.2 China Plasma Protein Therapeutics Market Size, 2016-2027
  6.5.3 Japan Plasma Protein Therapeutics Market Size, 2016-2027
  6.5.4 South Korea Plasma Protein Therapeutics Market Size, 2016-2027
  6.5.5 Southeast Asia Plasma Protein Therapeutics Market Size, 2016-2027
  6.5.6 India Plasma Protein Therapeutics Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Plasma Protein Therapeutics Revenue, 2016-2027
  6.6.2 Brazil Plasma Protein Therapeutics Market Size, 2016-2027
  6.6.3 Argentina Plasma Protein Therapeutics Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Plasma Protein Therapeutics Revenue, 2016-2027
  6.7.2 Turkey Plasma Protein Therapeutics Market Size, 2016-2027
  6.7.3 Israel Plasma Protein Therapeutics Market Size, 2016-2027
  6.7.4 Saudi Arabia Plasma Protein Therapeutics Market Size, 2016-2027
  6.7.5 UAE Plasma Protein Therapeutics Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Shire (Baxalta)
  7.1.1 Shire (Baxalta) Corporate Summary
  7.1.2 Shire (Baxalta) Business Overview
  7.1.3 Shire (Baxalta) Plasma Protein Therapeutics Major Product Offerings
  7.1.4 Shire (Baxalta) Plasma Protein Therapeutics Revenue in Global (2016-2021)
  7.1.5 Shire (Baxalta) Key News
7.2 CSL
  7.2.1 CSL Corporate Summary
  7.2.2 CSL Business Overview
  7.2.3 CSL Plasma Protein Therapeutics Major Product Offerings
  7.2.4 CSL Plasma Protein Therapeutics Revenue in Global (2016-2021)
  7.2.5 CSL Key News
7.3 Grifols
  7.3.1 Grifols Corporate Summary
  7.3.2 Grifols Business Overview
  7.3.3 Grifols Plasma Protein Therapeutics Major Product Offerings
  7.3.4 Grifols Plasma Protein Therapeutics Revenue in Global (2016-2021)
  7.3.5 Grifols Key News
7.4 Octapharma
  7.4.1 Octapharma Corporate Summary
  7.4.2 Octapharma Business Overview
  7.4.3 Octapharma Plasma Protein Therapeutics Major Product Offerings
  7.4.4 Octapharma Plasma Protein Therapeutics Revenue in Global (2016-2021)
  7.4.5 Octapharma Key News
7.5 Kedrion
  7.5.1 Kedrion Corporate Summary
  7.5.2 Kedrion Business Overview
  7.5.3 Kedrion Plasma Protein Therapeutics Major Product Offerings
  7.5.4 Kedrion Plasma Protein Therapeutics Revenue in Global (2016-2021)
  7.5.5 Kedrion Key News
7.6 LFB Group
  7.6.1 LFB Group Corporate Summary
  7.6.2 LFB Group Business Overview
  7.6.3 LFB Group Plasma Protein Therapeutics Major Product Offerings
  7.6.4 LFB Group Plasma Protein Therapeutics Revenue in Global (2016-2021)
  7.6.5 LFB Group Key News
7.7 Biotest
  7.7.1 Biotest Corporate Summary
  7.7.2 Biotest Business Overview
  7.7.3 Biotest Plasma Protein Therapeutics Major Product Offerings
  7.4.4 Biotest Plasma Protein Therapeutics Revenue in Global (2016-2021)
  7.7.5 Biotest Key News
7.8 BPL
  7.8.1 BPL Corporate Summary
  7.8.2 BPL Business Overview
  7.8.3 BPL Plasma Protein Therapeutics Major Product Offerings
  7.8.4 BPL Plasma Protein Therapeutics Revenue in Global (2016-2021)
  7.8.5 BPL Key News
7.9 RAAS
  7.9.1 RAAS Corporate Summary
  7.9.2 RAAS Business Overview
  7.9.3 RAAS Plasma Protein Therapeutics Major Product Offerings
  7.9.4 RAAS Plasma Protein Therapeutics Revenue in Global (2016-2021)
  7.9.5 RAAS Key News
7.10 CBPO
  7.10.1 CBPO Corporate Summary
  7.10.2 CBPO Business Overview
  7.10.3 CBPO Plasma Protein Therapeutics Major Product Offerings
  7.10.4 CBPO Plasma Protein Therapeutics Revenue in Global (2016-2021)
  7.10.5 CBPO Key News
7.11 Hualan Bio
  7.11.1 Hualan Bio Corporate Summary
  7.11.2 Hualan Bio Business Overview
  7.11.3 Hualan Bio Plasma Protein Therapeutics Major Product Offerings
  7.11.4 Hualan Bio Plasma Protein Therapeutics Revenue in Global (2016-2021)
  7.11.5 Hualan Bio Key News
7.12 Kamada
  7.12.1 Kamada Corporate Summary
  7.12.2 Kamada Business Overview
  7.12.3 Kamada Plasma Protein Therapeutics Major Product Offerings
  7.12.4 Kamada Plasma Protein Therapeutics Revenue in Global (2016-2021)
  7.12.5 Kamada Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Plasma Protein Therapeutics Market Opportunities & Trends in Global Market
Table 2. Plasma Protein Therapeutics Market Drivers in Global Market
Table 3. Plasma Protein Therapeutics Market Restraints in Global Market
Table 4. Key Players of Plasma Protein Therapeutics in Global Market
Table 5. Top Plasma Protein Therapeutics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Plasma Protein Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Plasma Protein Therapeutics Revenue Share by Companies, 2016-2021
Table 8. Global Companies Plasma Protein Therapeutics Product Type
Table 9. List of Global Tier 1 Plasma Protein Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Plasma Protein Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Plasma Protein Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Plasma Protein Therapeutics Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Plasma Protein Therapeutics Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Plasma Protein Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Plasma Protein Therapeutics Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Plasma Protein Therapeutics Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Plasma Protein Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Plasma Protein Therapeutics Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Plasma Protein Therapeutics Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Plasma Protein Therapeutics Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Plasma Protein Therapeutics Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Plasma Protein Therapeutics Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Plasma Protein Therapeutics Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Plasma Protein Therapeutics Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Plasma Protein Therapeutics Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Plasma Protein Therapeutics Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Plasma Protein Therapeutics Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Plasma Protein Therapeutics Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Plasma Protein Therapeutics Revenue, (US$, Mn), 2022-2027
Table 30. Shire (Baxalta) Corporate Summary
Table 31. Shire (Baxalta) Plasma Protein Therapeutics Product Offerings
Table 32. Shire (Baxalta) Plasma Protein Therapeutics Revenue (US$, Mn), (2016-2021)
Table 33. CSL Corporate Summary
Table 34. CSL Plasma Protein Therapeutics Product Offerings
Table 35. CSL Plasma Protein Therapeutics Revenue (US$, Mn), (2016-2021)
Table 36. Grifols Corporate Summary
Table 37. Grifols Plasma Protein Therapeutics Product Offerings
Table 38. Grifols Plasma Protein Therapeutics Revenue (US$, Mn), (2016-2021)
Table 39. Octapharma Corporate Summary
Table 40. Octapharma Plasma Protein Therapeutics Product Offerings
Table 41. Octapharma Plasma Protein Therapeutics Revenue (US$, Mn), (2016-2021)
Table 42. Kedrion Corporate Summary
Table 43. Kedrion Plasma Protein Therapeutics Product Offerings
Table 44. Kedrion Plasma Protein Therapeutics Revenue (US$, Mn), (2016-2021)
Table 45. LFB Group Corporate Summary
Table 46. LFB Group Plasma Protein Therapeutics Product Offerings
Table 47. LFB Group Plasma Protein Therapeutics Revenue (US$, Mn), (2016-2021)
Table 48. Biotest Corporate Summary
Table 49. Biotest Plasma Protein Therapeutics Product Offerings
Table 50. Biotest Plasma Protein Therapeutics Revenue (US$, Mn), (2016-2021)
Table 51. BPL Corporate Summary
Table 52. BPL Plasma Protein Therapeutics Product Offerings
Table 53. BPL Plasma Protein Therapeutics Revenue (US$, Mn), (2016-2021)
Table 54. RAAS Corporate Summary
Table 55. RAAS Plasma Protein Therapeutics Product Offerings
Table 56. RAAS Plasma Protein Therapeutics Revenue (US$, Mn), (2016-2021)
Table 57. CBPO Corporate Summary
Table 58. CBPO Plasma Protein Therapeutics Product Offerings
Table 59. CBPO Plasma Protein Therapeutics Revenue (US$, Mn), (2016-2021)
Table 60. Hualan Bio Corporate Summary
Table 61. Hualan Bio Plasma Protein Therapeutics Product Offerings
Table 62. Hualan Bio Plasma Protein Therapeutics Revenue (US$, Mn), (2016-2021)
Table 63. Kamada Corporate Summary
Table 64. Kamada Plasma Protein Therapeutics Product Offerings
Table 65. Kamada Plasma Protein Therapeutics Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Plasma Protein Therapeutics Segment by Type
Figure 2. Plasma Protein Therapeutics Segment by Application
Figure 3. Global Plasma Protein Therapeutics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Plasma Protein Therapeutics Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Plasma Protein Therapeutics Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Plasma Protein Therapeutics Revenue in 2020
Figure 8. By Type - Global Plasma Protein Therapeutics Revenue Market Share, 2016-2027
Figure 9. By Application - Global Plasma Protein Therapeutics Revenue Market Share, 2016-2027
Figure 10. By Region - Global Plasma Protein Therapeutics Revenue Market Share, 2016-2027
Figure 11. By Country - North America Plasma Protein Therapeutics Revenue Market Share, 2016-2027
Figure 12. US Plasma Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Plasma Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Plasma Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Plasma Protein Therapeutics Revenue Market Share, 2016-2027
Figure 16. Germany Plasma Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 17. France Plasma Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Plasma Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Plasma Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Plasma Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Plasma Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Plasma Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Plasma Protein Therapeutics Revenue Market Share, 2016-2027
Figure 24. China Plasma Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Plasma Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Plasma Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Plasma Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 28. India Plasma Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Plasma Protein Therapeutics Revenue Market Share, 2016-2027
Figure 30. Brazil Plasma Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Plasma Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Plasma Protein Therapeutics Revenue Market Share, 2016-2027
Figure 33. Turkey Plasma Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Plasma Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Plasma Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Plasma Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 37. Shire (Baxalta) Plasma Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. CSL Plasma Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Grifols Plasma Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Octapharma Plasma Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Kedrion Plasma Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. LFB Group Plasma Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Biotest Plasma Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. BPL Plasma Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. RAAS Plasma Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. CBPO Plasma Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Hualan Bio Plasma Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)